PMDA drug package insert
ビナキナールＨＧ顆粒
PMDA OTC drug · 東洋漢方製薬 · package insert Mar 3, 2023
Key facts
| Brand names | ビナキナールＨＧ顆粒 |
|---|---|
| Companies | 製造販売元／東洋漢方製薬, 株式会社,販売会社／源平製薬株式会社 |
| Product type | OTC drug |
| OTC risk class | 第２類医薬品 |
| OTC dosage form | 散剤 |
| OTC effect category | 排膿散 |
| Package insert date | Mar 3, 2023 |
| PMDA document key | 480188_K2303000002 |
| PMDA company code | 480188 |
At a glance
- 1–9 Package insert revisions
- None Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: